Revenue (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Net sales	$ 14,240	$ 12,682	$ 11,888
Contract with Customer, Liability [Abstract]
Contract with Customer, Liability	577	509
Change in Contract with Customer, Liability [Abstract]
Contract with Customer, Liability, Revenue Recognized	213
UNITED STATES
Disaggregation of Revenue [Line Items]
Net sales	8,425	7,632	6,911
Non-US [Member]
Disaggregation of Revenue [Line Items]
Net sales	5,816	5,111	4,978
EMEA [Member]
Disaggregation of Revenue [Line Items]
Net sales	2,856	2,526	2,518
APAC [Member]
Disaggregation of Revenue [Line Items]
Net sales	2,400	2,116	2,070
Latin America and Canada [Member]
Disaggregation of Revenue [Line Items]
Net sales	560	469	386
Emerging Markets [Member]
Disaggregation of Revenue [Line Items]
Net sales	2,310	1,968	1,656
country_US excluding Other Net Sales
Disaggregation of Revenue [Line Items]
Net sales	8,425	7,632	6,901
Global Endoscopy (Endo) Reporting Unit [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	2,482	2,221	2,141
Global Endoscopy (Endo) Reporting Unit [Member] | UNITED STATES | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,511	1,341	1,222
Global Endoscopy (Endo) Reporting Unit [Member] | Non-US [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	970	880	919
Global Urology and Pelvic Health Reporting Unit [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,964	1,773	1,583
Global Urology and Pelvic Health Reporting Unit [Member] | UNITED STATES | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,369	1,257	1,120
Global Urology and Pelvic Health Reporting Unit [Member] | Non-US [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	595	516	463
Global Neuromodulation (NM) Reporting Unit [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	976	917	909
Global Neuromodulation (NM) Reporting Unit [Member] | UNITED STATES | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	736	715	713
Global Neuromodulation (NM) Reporting Unit [Member] | Non-US [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	240	202	196
Global Peripheral Interventions (PI) Reporting Unit [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	2,110	1,899	1,820
Global Peripheral Interventions (PI) Reporting Unit [Member] | UNITED STATES | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,135	1,048	996
Global Peripheral Interventions (PI) Reporting Unit [Member] | Non-US [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	975	850	824
Interventional Cardiology Therapies | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	2,417	2,228	2,209
Interventional Cardiology Therapies | UNITED STATES | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	743	744	778
Interventional Cardiology Therapies | Non-US [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,674	1,485	1,431
Cardiac Rhythm Management | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	2,218	2,100	2,019
Cardiac Rhythm Management | UNITED STATES | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,405	1,337	1,214
Cardiac Rhythm Management | Non-US [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	813	763	805
Electrophysiology (EP) | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	800	585	365
Electrophysiology (EP) | UNITED STATES | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	370	275	128
Electrophysiology (EP) | Non-US [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	430	310	237
Watchman | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,274	1,019	829
Watchman | UNITED STATES | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,155	915	729
Watchman | Non-US [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	119	103	100
Global Cardiology Reporting Unit | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	6,709	5,932	5,422
Global Cardiology Reporting Unit | UNITED STATES | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	3,673	3,271	2,850
Global Cardiology Reporting Unit | Non-US [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	3,036	2,662	2,572
Other
Disaggregation of Revenue [Line Items]
Net sales	0	(60)	13
Other | UNITED STATES
Disaggregation of Revenue [Line Items]
Net sales	0	0	10
Other | Non-US [Member]
Disaggregation of Revenue [Line Items]
Net sales	0	0	4
MedSurg | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	5,422	4,911	4,633
MedSurg | UNITED STATES | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	3,617	3,312	3,055
MedSurg | Non-US [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	1,805	1,599	1,578
Cardiovascular | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	8,819	7,831	7,242
Cardiovascular | UNITED STATES | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	4,808	4,319	3,846
Cardiovascular | Non-US [Member] | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales	$ 4,011	$ 3,512	$ 3,396